PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Although aging is a known risk factor for idiopathic pulmonary fibrosis (IPF), the pathogenic mechanisms that underlie the effects of advancing age remain largely unexplained. Some age-related neurodegenerative diseases have an etiology that is related to mitochondrial dysfunction. Here, we found that alveolar type II cells (AECIIs) in the lungs of IPF patients exhibit marked accumulation of dysmorphic and dysfunctional mitochondria. These mitochondrial abnormalities in AECIIs of IPF lungs were associated with upregulation of ER stress markers and were recapitulated in normal mice with advancing age in response to stimulation of ER stress. We found that impaired mitochondria in IPF and aging lungs were associated with low expression of PTEN-induced putative kinase 1 (PINK1). Knockdown of PINK1 expression in lung epithelial cells resulted in mitochondria depolarization and expression of profibrotic factors. Moreover, young PINK1-deficient mice developed similarly dysmorphic, dysfunctional mitochondria in the AECIIs and were vulnerable to apoptosis and development of lung fibrosis. Our data indicate that PINK1 deficiency results in swollen, dysfunctional mitochondria and defective mitophagy, and promotes fibrosis in the aging lung.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“| Pulmonary fibrosis | Whole‐body deletion of Pink1 | Accelerated development of bleomycin‐induced lung fibrosis linked to accumulation of dysfunctional mitochondria in AEC cells | Bueno et al (2015) |”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al (2015)
In the citing paper
“Of note, the levels of PINK1 decline with age, suggesting that a time‐dependent drop in mitophagy proficiency may contribute to the development of pulmonary fibrosis in aged individuals (Bueno et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“In accordance with this notion, genetic loss of Pink1 and Prkn accelerates the development of the fibrotic phenotype in bleomycin‐treated mice, linked to alveolar epithelial cell II (AECII) loss and accrued inflammation (Bueno et al, 2015; Kobayashi et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Bueno et al, 2015
In the citing paper
“Pink1 deficiency leads to mitochondrial damage and hence promotes lung fibrosis (56), whereas a decreased expression of mitochondrial fission proteins Drp1 and mitochondrial fission 1 protein induces cellular senescence via a Pink1-dependent manner (57).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [56]
Citations
Cites
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 1×
“Mitochondrial materials such as mtDNA that leak from damaged mitochondria have been reported to elucidate inflammatory responses (48, 49).”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765 · cited 1×
“The median age of diagnosis of IPF is approximately 66 years (4, 5).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Whereas the familial disease has been related to mutations in surfactant proteins and telomerase, the cause of the majority of sporadic IPF cases and the mechanisms involved in aging-related IPF susceptibility are still unknown (6, 7).”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310
Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure
Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., et al. (2012) · Nature · doi:10.1038/nature10992 · Cited by 1,201
The role of mitochondria in aging
Bratic, A., & Larsson, N.-G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64125 · Cited by 1,087 · cited 1×
“Abnormalities in mitochondria are often observed with aging, including enlargement, loss of cristae, destruction of inner membranes, swelling, and impaired respiration (12).”
BackgroundDagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Self-citation
Research works printed but not linked: 2
- Crapo, 1978, Lab Invest., 39, 640
- Malhotra, 2011, Cold Spring Harb Perspect Biol., 3, a004424
Cited by
Items 201–300 of 624
Systemic inflammatory response syndrome is triggered by mitochondrial damage (Review)
Kong, C., Song, W., & Fu, T. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12663 · Cited by 51
“consistent with a previous study (48), Sliter et al (62) demonstrated that PinK1, a key gene in mitophagy that remove damaged mitochondria from cells, could inhibit STinG‐mediated inflammatory responses, thus providing a potential novel model for studing mitophagy, and attenuating the inflammatory response.”
BackgroundResultPINK1 ‐mediated mitophagy reduced inflammatory responses to Porphyromonas gingivalis in macrophages
Jiang, K., Li, J., Jiang, L., Li, H., & Lei, L. (2022) · Oral Diseases · doi:10.1111/odi.14286 · Cited by 51
Shao, M., Cheng, H., Li, X., Qiu, Y., Zhang, Y., Chang, Y., Fu, J., Shen, M., Xu, X., Feng, D., et al. (2024) · Theranostics · doi:10.7150/thno.94072 · Cited by 58
“Malfunctioning mitochondria have frequently been observed in AECII in the lungs of patients with idiopathic pulmonary fibrosis and mice with BLM-induced pulmonary fibrosis [22, 23].”
BackgroundMitochondria dysfunction: A novel therapeutic target in pathological lung remodeling or bystander?
Rowlands, D. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.019 · Cited by 49
Plasma membrane wounding and repair in pulmonary diseases
Cong, X., Hubmayr, R. D., Li, C., & Zhao, X. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00486.2016 · Cited by 50
“showed that ER stress triggers profibrotic factor expression in epithelial cells((29)) and promotes 676 EMT transition, providing a direct source of myofibroblasts in IPF((120)).”
BackgroundKim, S.-J., Cheresh, P., Eren, M., Jablonski, R. P., Yeldandi, A. V., Ridge, K. M., Budinger, G. R. S., Kim, D., Wolf, M. S., Vaughan, D. E., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00063.2017 · Cited by 51
Toll interacting protein protects bronchial epithelial cells from bleomycin‐induced apoptosis
Li, X., Kim, S. E., Chen, T., Wang, J., Yang, X., Tabib, T., Tan, J., Guo, B., Fung, S., Zhao, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902636rr · Cited by 46
Self-citationCheresh, P., Kim, S.-J., Jablonski, R. P., Watanabe, S., Lu, Z., Chi, M., Helmin, K. A., Gius, D. R., Budinger, G. R. S., & Kamp, D. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136856 · Cited by 53
Zhang, K., Zhang, D., Wang, J., Wang, Y., Hu, J., Zhou, Y., Zhou, X., Nie, S., & Xie, M. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119841 · Cited by 49
Wang, Y., Hu, L., Liu, N.-H., Yang, J.-S., Xing, L., Jeong, J., Li, L., & Jiang, H. (2024) · ACS Nano · doi:10.1021/acsnano.4c10328 · Cited by 53
Cicko, S., Grimm, M., Ayata, C. K., Beckert, J., Meyer, A., Hoßfeld, M., Zissel, G., Idzko, M., & Müller, T. (2015) · Respiratory Research · doi:10.1186/s12931-015-0264-9 · Cited by 50
“Recently, mitochondrial dysfunction has gained attention as a mechanism contributing to epithelial cell injury and the progression of pulmonary fibrosis [29, 30].”
BackgroundRegulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis
Gao, Y., Zhang, J., Liu, Y., Zhang, S., Wang, Y., Liu, B., Liu, H., Li, R., Lv, C., & Song, X. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0516-1 · Cited by 46
“[46] evaluated the mitochondria in the lung epithelial cells of human patients with IPF and proposed that dysfunctional mitochondria promotes fibrosis in an aging lung.”
BackgroundMitochondrial Quality Control in Age-Related Pulmonary Fibrosis
Roque, W., Cuevas-Mora, K., & Romero, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020643 · Cited by 46
“(16) Low expr ss on of PGC-1a was evidenced in patients wi h IPF and fibrotic mouse lungs aft r bleomycin treatment [19].”
BackgroundInfluentialZhou, X., Trinh‐Minh, T., Manh, C. T., Gießl, A., Bergmann, C., Györfi, A., Schett, G. A., & Distler, J. H. W. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42033 · Cited by 55
“Indeed, mitochondrial damage has been reported in idiopathic pulmonary fibrosis and connective tissue disease–associated interstitial lung disease (ILD) as well as in experimental models of ILD (33,34).”
BackgroundMorishita, R., Suzuki, T., Mukherjee, P., El-Sadek, I. A., Lim, Y., Lichtenegger, A., Makita, S., Tomita, K., Yamamoto, Y., Nagamoto, T., et al. (2023) · Biomedical Optics Express · doi:10.1364/boe.488097 · Cited by 49
“It is known that the disorder of alveolar cells causes serious lung diseases [13–15].”
Mitophagy and Mitochondrial Quality Control Mechanisms in the Heart
Gottlieb, R. A., & Thomas, A. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0133-y · Cited by 50
Mitochondrial dysfunction and chronic lung disease
Fang, T., Wang, M., Xiao, H., & Wei, X. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09473-9 · Cited by 49
“…activation of the mammalian target (mTOR) signaling pathway of platelet-derived growth factor receptor (PDGFR)/rapamycin the PDGFR-PI3K-AKT pathway activation, which enhances the conversion of fibroblasts to myofibroblasts and therefore promotes fibrosis (Bueno et al. 2015; Hawkins et al. 2015).”
BackgroundAutophagy in pulmonary fibrosis: friend or foe?
Hill, C. N., & Wang, Y. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.09.008 · Cited by 52
“Studies in vitro and in vivo demonstrated that knockdown of PINK1 resulted in dysfunctional mitochondria in ATII cells and defective mitophagy.(24) Further, TGF-b1 induced dysfunction of mitochondria and increased PINK1 expression, these changes were reversed by ROS scavenging.”
InfluentialCellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
Zhang, Y., & Wang, J. (2023) · Advances in respiratory medicine · doi:10.3390/arm91010005 · Cited by 53
“PTEN-induced putative kinase 1 (Pink1), an enzyme that promotes phagolysis of damaged mitochondria, is downregulated in IPF patients, and the degree of lung fibrosis is increased in Pink1-deficient mice, which is associated with reduced mitophagy, accumulation of malformed mitochondria, ER stress, and increased AT2 ap…”
BackgroundPeroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease
Elko, E. A., Cunniff, B., Seward, D. J., Chia, S. B., Aboushousha, R., van de Wetering, C., van der Velden, J. L. J., Manuel, A. M., Shukla, A., Heintz, N. H., et al. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7752 · Cited by 47
“Perturbations in mitochondria (12, 120) and, as mentioned earlier, the ER (13) have been implicated in the pathogenesis of IPF (88), although the extent to which redox perturbations originating from dysfunctional mitochondria or ER, respectively, contribute to IPF remains unclear.”
BackgroundKim, S.-J., Cheresh, P., Jablonski, R. P., Rachek, L. I., Yeldandi, A. V., Aillon, R. P., Ciesielski, M., Ridge, K. M., Gottardi, C. J., Lam, A. P., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00069.2019 · Cited by 48
Basit, F., & de Vries, I. J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02386 · Cited by 48
Bluhmki, T., Traub, S., Müller, A.-K., Groetzner, S., Schruf, E., Bammert, M., Leist, M., Gantner, F., Garnett, J. P., & Heilker, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-96565-4 · Cited by 54
Potential biomarkers and targets of mitochondrial dynamics
Li, L., Qi, R., Zhang, L., Yu, Y., Hou, J., Gu, Y., Song, D., & Wang, X. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.529 · Cited by 41
Tan, W. J. T., Song, L., Graham, M. M., Schettino, A. E., Navaratnam, D. S., Yarbrough, W. G., Santos‐Sacchi, J., & Ivanova, A. V. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6851 · Cited by 44
“It is a critical protector from age-related diseases linked to dysfunctional mitochondria (7, 54).”
BackgroundLiu, Y., Zhong, W., Zhang, J., Chen, W., Lu, Y., Qiao, Y., Zeng, Z., Huang, H., Zou, F., 孟小晶, et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739220 · Cited by 46
“pMLFs were isolated using a method described previously (Bueno et al., 2015).”
MethodReciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis
Liang, J., Huang, G., Liu, X., Taghavifar, F., Liu, N., 姚昌富, Deng, N., Wang, Y., Burman, A., Xie, T., et al. (2023) · eLife · doi:10.7554/elife.85415 · Cited by 44
The aging lung: microenvironment, mechanisms, and diseases
Wang, Y., Huang, X., Luo, G., Xu, Y., Deng, X., Lin, Y., Wang, Z., Zhou, S., Wang, S., Chen, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1383503 · Cited by 66
Korfei, M., MacKenzie, B., & Meiners, S. (2020) · European Respiratory Review · doi:10.1183/16000617.0126-2020 · Cited by 45
The integrated stress response in pulmonary disease
Emanuelli, G., Nassehzadeh-Tabriz, N., Morrell, N. W., & Marciniak, S. J. (2020) · European Respiratory Review · doi:10.1183/16000617.0184-2020 · Cited by 45
Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle
Li, X., Goobie, G. C., Gregory, A. D., Kass, D. J., & Zhang, Y. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0470tr · Cited by 52
Wei, Y., Sun, L., Liu, C., & Li, L. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02390-z · Cited by 41
ACSS3 regulates the metabolic homeostasis of epithelial cells and alleviates pulmonary fibrosis
Wang, L., Yuan, H., Li, W., Yan, P., Zhao, M., Li, Z., Zhao, H., Wang, S., Wan, R., Li, Y., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166960 · Cited by 49
Zhang, Y., Liu, J., Zheng, R., Hou, K., Zhang, Y., Jia, T., Lu, X., Samarawickrama, P. N., Jia, S., He, Y., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155882 · Cited by 49
Role of mitochondria in inflammatory lung diseases
Narala, V. R., Narala, S. R., Subramani, P. A., Panati, K., & Kolliputi, N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1433961 · Cited by 50
Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: A review
Tian, Y., Duan, C., Feng, J., Liao, J., Yang, Y., & Sun, W. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106361 · Cited by 43
Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
Luckhardt, T., & Thannickal, V. J. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000219 · Cited by 41
Xu, Z.-X., Li, J.-Z., Li, Q., Xu, M., & Li, H. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.008 · Cited by 40
Mitochondrial quality control in lung diseases: current research and future directions
Liu, J., Wang, J., Xiong, A., Zhang, L., Zhang, Y., Liu, Y., Xiong, Y., Li, G., & He, X. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1236651 · Cited by 42
“It has been found that MFN2 plays a role in linking mitochondria to the ER during ER stress (Bueno et al., 2015).”
BackgroundMitochondrial biology in airway pathogenesis and the role of NRF2
Cho, H., & Kleeberger, S. R. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01182-5 · Cited by 44
Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Roy, S., Dhaneshwar, S. S., & Bhasin, B. (2021) · Current Drug Research Reviews · doi:10.2174/2589977513666210211163711 · Cited by 42
Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis
Sui, J., Boatz, J. C., Shi, J., Hu, Q., Li, X., Zhang, Y., Königshoff, M., & Kliment, C. R. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0315oc · Cited by 45
Lee, J.-U., Song, K. S., Hong, J., Shin, H., Park, E. J., Baek, J., Park, S., Baek, A.-R., Lee, J.-H., Jang, A. S., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01170-w · Cited by 43
Self-citationLiu, N., Fan, X., Shao, Y., Chen, S., Wang, T., Yao, T., & Chen, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05228-1 · Cited by 43
“Deficiency of PINK1 disrupts mitochondrial homeostasis and facilitates the development of lung fibrosis [47].”
BackgroundBarnes, P. J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_3 · Cited by 40
Lipoxin A4 reduces hyperoxia-induced lung injury in neonatal rats through PINK1 signaling pathway
Wu, Q., Chong, L., Shao, Y., Chen, S., & Li, C. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.046 · Cited by 39
Lee, H. Y., Nam, S., Kim, M. J., Kim, S. J., Back, S. H., & Yoo, H. J. (2021) · Metabolites · doi:10.3390/metabo11050258 · Cited by 40
“Significant accumulation of dysfunctional mitochondria in fibrotic lungs is associated with the development of pulmonary fibrosis [30,34,37].”
BackgroundMattoo, H., & Pillai, S. S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03874-y · Cited by 40
CB 1 R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky–Pudlak syndrome
Çınar, R., Park, J. K., Zawatsky, C. N., Coffey, N. J., Bodine, S. P., Abdalla, J., Yokoyama, T., Jourdan, T., Jay, L., Zuo, M. X. G., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.471 · Cited by 36
Wang, L., Zhu, T., Feng, D., Li, R., & Zhang, C. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500434 · Cited by 46
Chu, L., Zhuo, J., Huang, H., Chen, W., Zhong, W., Zhang, J., Meng, X., Zou, F., Cai, S., Zou, M., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176459 · Cited by 44
Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI
Sun, N., Fernandez, I. E., Wei, M., Witting, M. A., Aichler, M., Feuchtinger, A., Burgstaller, G., Verleden, S. E., Schmitt‐Kopplin, P., Eickelberg, O., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02314-2017 · Cited by 36
Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
Miller, E. R., Putman, R. K., Díaz, A. A., Xu, H., Estépar, R. S. J., Araki, T., Nishino, M., Poli, S., Hida, T., Ross, J. C., et al. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201806-424oc · Cited by 39
Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma
Bueno, M., Papazoglou, A., Valenzi, E., Rojas, M. M., Lafyatis, R., & Mora, A. L. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00920-9 · Cited by 40
Self-citationSelman, M., Martinez, F. J., & Pardo, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1166pp · Cited by 35
Shimbori, C., Bellaye, P., Kolb, P., & Kolb, M. R. J. (2017) · Milestones in drug therapy · doi:10.1007/978-3-0348-0977-1_3 · Cited by 38
Xiao, H., Peng, L., Jiang, D., Liu, Y., Zhu, L., Li, Z., Geng, J., Xie, B., Huang, X., Wang, J., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17600 · Cited by 37
Role of cellular senescence in inflammatory lung diseases
Xie, C. H., Yalikun, M., Luo, Q., & Dong, J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.02.001 · Cited by 33
Endometrial organoids: a reservoir of functional mitochondria for uterine repair
Hwang, S., Lee, D., Lee, G., Ahn, J., Lee, Y., Koo, H. S., & Kang, Y. (2024) · Theranostics · doi:10.7150/thno.90538 · Cited by 36
Luis‐García, E. R., Becerril, C., Salgado-Aguayo, A. R., Aparicio‐Trejo, O. E., Romero, Y., Flores‐Soto, E., Mendoza-Milla, C., Montaño, M., de Sánchez, V. C., Pedraza‐Chaverrí, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157870 · Cited by 38
“The mechanisms of this paradoxical behavior are uncertain, but in the case of epithelial cells, their susceptibility has been attributed, at least partially, to mitochondrial dysfunction [5].”
BackgroundSelf-citationZhou, J., Wang, Z., He, Y., Luo, X., Zhang, W., Li, Y., Chen, X., He, X., Yuan, Y., Wang, X., et al. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02992-7 · Cited by 33
Yoon, Y. M., Kim, H. J., Lee, J. H., & Lee, S. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184545 · Cited by 34
“The resulting ROS-mediated uncoupling of the electron transport chain further induces distortions in mitochondrial morphology through elongation and fusion [42,43].”
BackgroundSelf-citationMechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches
Mohammed, S. M., Al-Saedi, H. F. S., Mohammed, A. Q., Amir, A. A., Radi, U. K., Sattar, R., Ahmad, I., Ramadan, M. F., Alshahrani, M. Y., Balasim, H. M., et al. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01384-9 · Cited by 46
Wu, Q., Xu, T., Liu, Y., Li, Y., Yuan, J., Yao, W., Xu, Q., Yan, W., & Ni, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112357 · Cited by 33
“Fo example, mito hagy molecular PINK1 is decrease in typ II alveolar epithelial cells from the IPF lung, and PINK1 reduction ca sed accumulation of damaged mitochondria, loss of ce l viability, and ac ivation of profibrotic responses [27].”
PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis
Ganzleben, I., He, G.-W., Günther, C., Prigge, E., Richter, K., Rieker, R. J., Mougiakakos, D., Neurath, M. F., & Becker, C. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03133-1 · Cited by 35
“In contrast, other studies have described substantial beneficial effects of mitophagy in IPF with a deficiency leading to aggravated pulmonary fibrosis [7, 8].”
BackgroundResultInterstitial Lung Disease in Elderly Rheumatoid Arthritis Patients
Messina, R., Guggino, G., Benfante, A., & Scichilone, N. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00727-z · Cited by 31
miR-155 inhibits mitophagy through suppression of BAG5, a partner protein of PINK1
Tsujimoto, T., Mori, T., Houri, K., Onodera, Y., Takehara, T., Shigi, K., Nakao, S., Teramura, T., & Fukuda, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.022 · Cited by 34
Faniyi, A. A., Hughes, M., Scott, A., Belchamber, K. B. R., & Sapey, E. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15759 · Cited by 35
“In response to ER stress and age, mitochondria in AECIIs were shown to have altered respiration and bioenergetics and impaired fission and fusion using murine and cellular models, with AECIIs from IPF lungs also demonstrating an accumulation of dysfunctional mitochondria (Bueno et al., 2015).”
BackgroundNam, J.-H., Lee, J., Choi, H., Choi, S.-Y., Noh, K.-E., Jung, N.-C., Song, J. Y., Choi, J., Seo, H. G., Jung, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105650 · Cited by 37
“Recent reports have suggested that PINK1 is down regulated during the pro-fibrotic response, increasing susceptibility to lung fibrosis [17,18].”
BackgroundSelf-citationCelastrol: The new dawn in the treatment of vascular remodeling diseases
Tan, J.-L., Yi, J., Cao, X.-Y., Wang, F., Xie, S.-L., Zhou, L., Li, Q., & Dai, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114177 · Cited by 31
He, Q., Li, P., Han, L., Yang, C. G., Jiang, M., Wang, Y., Han, X., Cao, Y., Liu, X., & Wu, W. (2024) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00362.2023 · Cited by 42
Romero, F., & Summer, R. S. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201703-207aw · Cited by 36
WNT Signalling in Lung Physiology and Pathology
Hu, Y., Ciminieri, C., Hu, Q., Lehmann, M., Königshoff, M., & Gosens, R. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_521 · Cited by 34
Liu, H., Bai, X., Wei, W., Li, Z., Zhang, Z., Tan, W., Wei, B., Zhao, H., & Jiao, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/9969729 · Cited by 32
“In line with previous research [45], numerous dysmorphic and enlarged mitochondria, and few autophagic vesicles were observed in lung tissues after BLM administration.”
ResultAdvances in cellular senescence in idiopathic pulmonary fibrosis (Review)
Han, S., Lu, Q., & Liu, X. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11844 · Cited by 34
“The association between mitochondrial dysfunction and low PINK1 expression indicates that PINK1 may serve an important role in maintaining the morphology and function of mitochondria and selectively degrades damaged mitochondria through autophagy (31).”
InfluentialMohanan, A., Washimkar, K. R., & Mugale, M. N. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119676 · Cited by 39
Li, S., Yang, F., Fang, C. R., Zhu, L., & Yan, Y. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00596-4 · Cited by 38
New Perspectives on the Aberrant Alveolar Repair of Idiopathic Pulmonary Fibrosis
Wang, Z. N., & Tang, X. X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.580026 · Cited by 35
“The death of AEC2 is associated with activation of apoptotic pathway (Maeyama et al., 2001), increased endoplasmic reticulum (ER) stress (Korfei et al., 2008) and mitochondrial dysfunction (Bueno et al., 2015).”
BackgroundPulmonary endoplasmic reticulum stress—scars, smoke, and suffocation
Dickens, J. A., Malzer, E., Chambers, J. E., & Marciniak, S. J. (2018) · FEBS Journal · doi:10.1111/febs.14381 · Cited by 31
PINK1 Expression Is Associated with Poor Prognosis in Lung Adenocarcinoma
Chang, G., Zhang, W., Ma, Y., & Wen, Q. (2018) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.245.115 · Cited by 31
Cheresh, P., Kim, S.-J., Huang, L. S., Watanabe, S., Joshi, N., Williams, K. J. N., Chi, M., Lu, Z., Harijith, A. K., Yeldandi, A. V., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165595 · Cited by 30
Role and mechanisms of autophagy in lung metabolism and repair
Li, X., Zhao, F., Wang, A., Cheng, P., & Chen, H. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03841-7 · Cited by 34
“Accumulating evidence illustrates there are many dysfunctional mitochondria in the alveolar epithelial cells of IPF lung tissue [170].”
BackgroundLiu, L., Zhang, X., Zhang, R., Wang, L., Zhi, S., Feng, X., Liu, X., Shen, Y., & Hao, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06179-z · Cited by 32
Autophagy and Obesity-Related Lung Disease
Pabón, M. A., Ma, K. C., & Choi, A. M. K. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0045ps · Cited by 34
“The role PINK1 expression plays in the lungs of patients with IPF is controversial because there are reports on high (111) and low (112) levels”
BackgroundSun, L. V., Zhang, J., Chen, W., Chen, Y., Zhang, X., Yang, M., Xiao, M., Ma, F., Yao, Y., Ye, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13210 · Cited by 34
Double-edged mitophagy: balancing inflammation and resolution in lung disease
Tian, S., Zhang, Y., Liu, C. X., Zhang, H., Lu, Q., Zhao, Y., & Fan, H. (2025) · Clinical Science · doi:10.1042/cs20256705 · Cited by 41
Rackow, A. R., Nagel, D. J., McCarthy, C., Judge, J., Lacy, S. H., Freeberg, M. A. T., Thatcher, T. H., Kottmann, R. M., & Sime, P. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.00075-2020 · Cited by 31
Huang, S., Hong, Z., Zhang, L., Guo, J. M., Lǐ, Y., & Li, K. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0411 · Cited by 28
Mitochondrial dysfunction and quality control lie at the heart of subarachnoid hemorrhage
Zhang, J.-T., Zhu, Q., Wang, J., Peng, Z., Zhuang, Z., Hang, C., & Li, W. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.381493 · Cited by 30
“For instance, PINK1 deficiency in lung epithelial cells leads to mitochondrial depolarization, pro-fibrotic factor expression, and pulmonary fibrosis, suggesting a mitogenic protective function of the PINK1/parkin pathway in idiopathic pulmonary fibrosis (Bueno et al., 2015).”
BackgroundMitochondria Regulate the Differentiation of Stem Cells from Human Exfoliated Deciduous Teeth
Kato, H., Pham, T. T. M., Yamaza, H., Masuda, K., Hirofuji, Y., Han, X., Sato, H., Taguchi, T., & Nonaka, K. (2017) · Cell Structure and Function · doi:10.1247/csf.17012 · Cited by 29
Guo, F., Xu, F., Li, S., Zhang, Y., Lv, D., Zheng, L., Gan, Y., Zhou, M., Zhao, K., Xu, S., et al. (2024) · European journal of medical research · doi:10.1186/s40001-023-01623-4 · Cited by 30
“These are recognized as distinctive features of IPF lungs [4–6].”
BackgroundMAM kinases: physiological roles, related diseases, and therapeutic perspectives—a systematic review
Mohan, A. A., & Talwar, P. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00714-w · Cited by 31
“The young mouse model also showed manifestations of swollen and dysfunctional mitochondria and lung fibrosis upon lack of PINK1 [200].”
Zheng, C., Zhang, L., Sun, Y., Ma, Y., & Zhang, Y. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1564176 · Cited by 37
Role of mitochondria transmission in ischemic stroke: Friend or foe?
Yang, L., Wei, X., Liao, Z., Chen, B., Zeng, G., & Mei, Z. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103868 · Cited by 30
Update on the role of endoplasmic reticulum stress in asthma.
Miao, K., Zhang, L., Pan, T. S., & Wang, Y. (2020) · American Journal of Translational Research · Cited by 33
Interactions of Autophagy and the Immune System in Health and Diseases
Pant, A., Yao, X., Lavedrine, A., Viret, C., Dockterman, J., Chauhan, S. C., Shi, C.-S., Manjithaya, R. R., Cadwell, K., Kufer, T. A., et al. (2022) · Autophagy Reports · doi:10.1080/27694127.2022.2119743 · Cited by 32
Targeting Mitochondria to Control Ageing and Senescence
Protasoni, M., & Serrano, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020352 · Cited by 31
“Moreover, both fission and mitophagy efficiency can be worsened with ageing because of a reduced expression of PINK1 [77], which, together with Parkin, is the main actor of the mitochondrial clearance pathway [78].”
BackgroundKanno, S., Hirano, S., Mukai, T., Ro, A., Kato, H., Fukuta, M., & Aoki, Y. (2018) · Legal Medicine · doi:10.1016/j.legalmed.2018.11.008 · Cited by 31
Wu, W., Jia, H., Chen, S., Ma, X., Zhou, S. F., Qiu, L., Wu, X., Li, P., Chu, H., & Zhang, G. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00843-6 · Cited by 30
Cadena-Suárez, A. R., Hernández-Hernández, H. A., Alvarado‐Vásquez, N., Rangel‐Escareño, C., Sommer, B., & Negrete-García, M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126613 · Cited by 31
“[8] reported that alveolar epithelial cells type II (AECIIs) from lungs of IPF patients exhibited an accumulation of dysfunctional mitochondria, a fact associated with upregulation of endoplasmic reticulum (ER) stress.”
Background
Metadata
- Authors
- Bueno, M., Lai, Y.-C., Romero, Y., Brands, J., St. Croix, C. M., Kamga, C., Corey, C., Herazo-Maya, J. D., Sembrat, J., Lee, J. S., Duncan, S. R., Rojas, M., Shiva, S., Chu, C. T., & Mora, A. L.
- Affiliations
- University of Pittsburgh (US)
- Universidad Nacional Autónoma de México (MX)
- Corresponding author
- Mora, Ana L.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-12-22
- Volume
- 125
- Issue
- 2
- Pages
- 521-538
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319413
- OpenAlex
- W2054760729
- Cited by
- 627
- References
- 65
- Citations by year
- 2026: 50 · 2025: 63 · 2024: 74 · 2023: 63 · 2022: 49 · 2021: 68 · 2020: 59 · 2019: 57 · 2018: 49 · 2017: 42 · 2016: 33 · 2015: 18
- FWCI
- 24.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Hemophilia Center of Western Pennsylvania
- National Institutes of Health (DK072506, NS065789)
- National Institute on Aging (AG026389, R01AG026389)
- National Heart, Lung, and Blood Institute (R01HL086884, R01HL123766)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072506)
- National Institute of Neurological Disorders and Stroke (NS065789, R01NS065789, R56NS065789)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- PINK1, idiopathic pulmonary fibrosis, lung aging, mitochondrial dysfunction, alveolar type II cells, endoplasmic reticulum stress, mitophagy, mitochondrial depolarization, apoptosis, mitochondrial homeostasis
- MeSH terms
- PTEN-Induced Putative Kinase, Aging, Animals, Humans, Mice, Inbred BALB C, Mitochondria, Protein Kinases, Pulmonary Alveoli, Up-Regulation, Apoptosis, Mice, Knockout, Cell Line, Tumor, Mice, Idiopathic Pulmonary Fibrosis, Endoplasmic Reticulum Stress, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.